Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) 07/06/2023 INTERVENTIONAL unchanged 1,147.85 0 Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise 07/07/2023 INTERVENTIONAL unchanged 1,146.85 0 A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia 07/07/2023 INTERVENTIONAL unchanged 1,146.85 0 Omission of SLNB in CN0 Early Breast Cancer 07/07/2023 INTERVENTIONAL unchanged 1,146.85 0 Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery 07/10/2023 INTERVENTIONAL unchanged 1,143.85 0 EEG and ANI Guided Anesthesia and Quality of Recovery 07/10/2023 INTERVENTIONAL unchanged 1,143.85 0 Quantum Menstrual Health Monitoring Study 07/10/2023 OBSERVATIONAL unchanged 1,143.85 0 Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer 07/10/2023 INTERVENTIONAL unchanged 1,143.85 0 Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia 07/10/2023 INTERVENTIONAL unchanged 1,143.85 0 MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA) 07/10/2023 OBSERVATIONAL unchanged 1,143.85 0 Multimodality Treatments of HPV-related Lesions of the Female Genital Tract 07/10/2023 OBSERVATIONAL unchanged 1,143.85 0 Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT 07/10/2023 OBSERVATIONAL unchanged 1,143.85 0 Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study 07/11/2023 OBSERVATIONAL unchanged 1,142.85 0 Mavacamten Pregnancy Surveillance Program 07/11/2023 OBSERVATIONAL unchanged 1,142.85 0 Omission of ALND in Breast Cancer Patients With Axillary pCR 07/11/2023 INTERVENTIONAL unchanged 1,142.85 0 Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy 07/12/2023 INTERVENTIONAL unchanged 1,141.85 0 Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer 07/12/2023 INTERVENTIONAL unchanged 1,141.85 0 ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques. 07/12/2023 OBSERVATIONAL unchanged 1,141.85 0 Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study 07/12/2023 OBSERVATIONAL unchanged 1,141.85 0 Comparison Between ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion by Randomized Clinical Study. 07/12/2023 OBSERVATIONAL unchanged 1,141.85 0 CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer 07/12/2023 INTERVENTIONAL unchanged 1,141.85 0 Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy 07/12/2023 OBSERVATIONAL unchanged 1,141.85 0 Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 The Osteoarthritis Prevention Study 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 Alternative Healthcare Delivery Strategies to Prevent Weight Regain After Bariatric Surgery 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 Role of NADPH Oxidase in Microvascular Dysfunction Following GDM 07/14/2023 INTERVENTIONAL unchanged 1,139.85 0 Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial 07/17/2023 INTERVENTIONAL unchanged 1,136.85 0 Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy 07/17/2023 INTERVENTIONAL unchanged 1,136.85 0 OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer 07/17/2023 INTERVENTIONAL unchanged 1,136.85 0 Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer 07/18/2023 INTERVENTIONAL unchanged 1,135.85 0 Harnessing Human Potential and Improving Health Span in Women and Their Children 07/18/2023 INTERVENTIONAL unchanged 1,135.85 0 Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer 07/18/2023 INTERVENTIONAL unchanged 1,135.85 0 Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy 07/18/2023 OBSERVATIONAL unchanged 1,135.85 0 Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer 07/18/2023 INTERVENTIONAL unchanged 1,135.85 0 Adolescent Girls Initiative for Learning and Empowerment: Impact Evaluation of a Safe Space-Based Life Skills Training and Digital Literacy Training in Nigeria Space-Based Life Skills Training and Digital Literacy Training in Nigeria 07/19/2023 INTERVENTIONAL unchanged 1,134.85 0 Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana 07/19/2023 INTERVENTIONAL unchanged 1,134.85 0 Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro 07/19/2023 INTERVENTIONAL unchanged 1,134.85 0 VALOR: Vaginal Atrophy & Long-term Observation of Recovery 07/19/2023 INTERVENTIONAL unchanged 1,134.85 0 A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring 07/20/2023 OBSERVATIONAL unchanged 1,133.85 0 Presacral Nerve Block Versus Sham Block on Post-operative Pain for Total Laparoscopic Hysterectomy 07/20/2023 INTERVENTIONAL unchanged 1,133.85 0 Proteogenomic Signatures Analysis In Ovarian Cancer 07/20/2023 INTERVENTIONAL unchanged 1,133.85 0 Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype 07/20/2023 INTERVENTIONAL unchanged 1,133.85 0 Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia 07/21/2023 INTERVENTIONAL unchanged 1,132.85 0 Exosome as the Prognostic and Predictive Biomarker in EBC Patients 07/21/2023 INTERVENTIONAL unchanged 1,132.85 0 Evaluation of Diffusion Tensor Imaging and High Frequency 3D Endovaginal Ultrasound 07/21/2023 INTERVENTIONAL unchanged 1,132.85 0 Breast Cancer Exercise Intervention Study 07/24/2023 INTERVENTIONAL unchanged 1,129.85 0 Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle 07/25/2023 OBSERVATIONAL unchanged 1,128.85 0 Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer 07/27/2023 INTERVENTIONAL unchanged 1,126.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology